Cornerstone Therapeutics News

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

06.09.17	OKI Data Americas to Demonstrate Breakthroughs in White and Color-on-Color Printing Capabilities at PRINT 17 (PR Newswire)
05.09.17	CI Capital Partners Acquires Summit Companies (PR Newswire)
05.05.17	PBF Energy to Attend Industry Conferences (PR Newswire)
18.10.13	Cornerstone Therapeutics Inc. Stockholders Seeking More Money Regarding the Proposed Buyout by Chiesi Farmaceutici S.P.A. Encouraged to Contact Lawyers at Deans & Lyons (PR Newswire)
26.09.13	SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Announces Investigation Of Cornerstone Therapeutics, Inc. Buyout (PR Newswire)
17.09.13	Ryan & Maniskas, LLP Announces Investigation of Cornerstone Therapeutics Inc. (PR Newswire)
17.09.13	Chiesi Farmaceutici und Cornerstone Therapeutics kündigen eine Fusionstransaktion an, bei der Chiesi 100 Prozent Eigentum an Cornerstone für 9,50 USD pro Aktie in bar erwerben wird (PR Newswire)
17.09.13	SHAREHOLDER ALERT: Law Office of Brodsky & Smith, LLC Announces Investigation of Cornerstone Therapeutics, Inc. (PR Newswire)
17.09.13	Chiesi Farmaceutici et Cornerstone Therapeutics annoncent un accord de fusion en vertu duquel Chiesi acquerra la totalité de Cornerstone pour 9,50 $ par action en numéraire (PR Newswire)
16.09.13	Chiesi Farmaceutici and Cornerstone Therapeutics Announce Agreement for a Merger Transaction in Which Chiesi Will Acquire 100 Percent Ownership of Cornerstone for $9.50 Per Share in Cash (PR Newswire)
16.09.13	Chiesi Farmaceutici and Cornerstone Therapeutics Announce Agreement for a Merger Transaction in Which Chiesi Will Acquire 100 Percent Ownership of Cornerstone for $9.50 Per Share in Cash (PR Newswire)
20.05.08	Critical Therapeutics Receives Notice of Additional Deficiency from NASDAQ (Businesswire)
01.05.08	Critical Therapeutics Signs Definitive Agreement to Merge with Cornerstone BioPharma (Businesswire)
27.03.08	Critical Therapeutics Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007 (Businesswire)
08.11.07	Critical Therapeutics Reports Financial Results for the Three and Nine Months Ended September 30, 2007 (Businesswire)
10.10.07	Critical Therapeutics Announces the Issuance of Four New Patents for Its Alpha-7 and HMGB1 Preclincial Programs (Businesswire)
08.10.07	Critical Therapeutics and Dey, L.P. Launch Perforomist(TM) (Formoterol Fumarate) Inhalation Solution (Businesswire)
03.01.05	Critical Therapeutics to Present at Upcoming Biotechnology and Healthc (Businesswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

ABB	50.28	1.62 %	K V
UBS Group	28.48	1.42 %	K V
CieFinRichemont	122.70	1.24 %	K V
Lonza Grp	526.40	1.15 %	K V
Part Grp Hldg	1’280.00	1.11 %	K V
Sonova Hldg	300.80	-0.07 %	K V
Sika	228.10	-0.09 %	K V
Novartis	93.27	-0.12 %	K V
Nestle	76.48	-0.21 %	K V
Swisscom	508.50	-0.29 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Cornerstone Therapeutics Inc Cash Settlement At USD 9.50 A Sh

Aktien Top/Flop

Meistgelesene Nachrichten